Migraine

• CLINICAL_TRIALS trial_result · 2025-04-16
  Clinical Trial Update: A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age [Phase 3]

  A Phase 3 pediatric trial of fremanezumab for preventing episodic migraine in ages 6 to 17 has completed and posted results.

• CLINICAL_TRIALS trial_result · 2025-04-11
  Clinical Trial Update: Oxygen in Migraine Treatment

  A completed clinical trial from Ankara Ataturk Sanatorium Training and Research Hospital evaluated oxygen therapy for migraine treatment (NC…

• CLINICAL_TRIALS trial_result · 2025-04-06
  Clinical Trial Update: Clinical Decision Support for Patient Migraine Management [NA]

  A completed clinical trial evaluated a decision-support tool to aid migraine management. Results were posted on 2025-04-06.

• CLINICAL_TRIALS trial_result · 2025-03-30
  Clinical Trial Update: The Effect of Galcanezumab-gnlm on Post-Traumatic, Migrainous Headaches [Phase 4]

  A Phase 4 clinical trial evaluating galcanezumab-gnlm for post-traumatic migrainous headaches has completed.

• CLINICAL_TRIALS trial_result · 2025-03-30
  Clinical Trial Update: A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults.

  Pfizer-sponsored real-world observational study evaluating the acute treatment of migraine attacks in adults with rimegepant ODT. The study …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-03-27
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention [Phase 2, Phase 3]

  Pfizer's oral zavegepant was evaluated for migraine prevention in Phase 2/Phase 3 trials. The study was terminated and results have been pos…

• CLINICAL_TRIALS trial_result · 2025-03-24
  Clinical Trial Update: (Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist [Phase 4]

  Phase 4 trial evaluating onabotulinumtoxinA (Botox) for migraine to understand its mechanism of action on the molecular environment around p…

• CLINICAL_TRIALS trial_result · 2025-03-17
  Clinical Trial Update: Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine [Phase 3]

  Phase 3 study evaluating oral atogepant for episodic migraine in adult Japanese participants has completed.

• CLINICAL_TRIALS trial_result · 2025-03-17
  Clinical Trial Update: Investigation of the Effect of Cold Application in Migraine [NA]

  A completed clinical trial evaluated the effect of cold application on migraine. The study context also mentions relaxation and exercise as …

• CLINICAL_TRIALS trial_result · 2025-03-12
  Clinical Trial Update: A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents [Phase 3]

  Phase 3 pilot trial evaluating an investigational neuromodulation device for acute migraine attacks in children and adolescents has complete…

• CLINICAL_TRIALS trial_result · 2025-03-12
  Clinical Trial Update: A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants [Phase 1]

  Vaxxinity reports Phase 1 results assessing the safety, tolerability, and immunogenicity of UB-313 in healthy participants for migraine.

• CLINICAL_TRIALS trial_result · 2025-03-12
  Clinical Trial Update: The Effect of a Video-Based Exercise Program on Migraine Symptoms [NA]

  This clinical trial update reports a study evaluating the impact of a video-based exercise program on migraine symptoms. Enrollment is by in…

• CLINICAL_TRIALS trial_result · 2025-03-11
  Clinical Trial Update: Craniocervical Flexion Training for Reducing Migraine Headaches and Disability [NA]

  This clinical trial update reports the completion of a study evaluating craniocervical flexion training for reducing migraine headaches and …

• CLINICAL_TRIALS trial_result · 2025-03-10
  Clinical Trial Update: The Effect of Different Exercise Types on Migraine Frequency in Individuals With Migraine [NA]

  A completed clinical trial from Ege University evaluated how different exercise types affect migraine frequency in individuals with migraine…

• CLINICAL_TRIALS trial_result · 2025-02-25
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine [Phase 2]

  Phase 2 study evaluating the efficacy and safety of TNX-1900 in chronic migraine has completed and results have been posted.

• CLINICAL_TRIALS trial_result · 2025-02-24
  Clinical Trial Update: Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg Vs Placebo As Adjuvant Treatment in Chronic Migraine - [Phase 2, Phase 3]

  A Phase 2/Phase 3 trial evaluating a CBD/CBG/THC combination as adjuvant therapy for chronic migraine and related headaches was terminated.

• CLINICAL_TRIALS trial_result · 2025-02-20
  Clinical Trial Update: A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants [Phase 3]

  Phase 3 study evaluating the long-term safety of rimegepant for acute treatment of migraine in Chinese participants has completed. Results h…

• CLINICAL_TRIALS trial_result · 2025-02-19
  Clinical Trial Update: Comparison of Neuromodulatory Treatment of Migraine Headache with Acupuncture and Transcranial Direct Current Stimulation [NA]

  A clinical trial comparing acupuncture to transcranial direct current stimulation for migraine is currently enrolling by invitation.

• CLINICAL_TRIALS trial_result · 2025-02-14
  Clinical Trial Update: Efficacy and Safety of Rizatriptan-Naproxen (10/550 Mg) in the Acute Treatment of Migraine [Phase 3]

  A Phase 3 clinical trial evaluating the efficacy and safety of rizatriptan-naproxen (10/550 mg) for the acute treatment of migraine has been…

• CLINICAL_TRIALS trial_result · 2025-02-10
  Clinical Trial Update: Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only) [Phase 3]

  A Phase 3 study in Japanese adults evaluated the efficacy and safety of rimegepant (Nurtec ODT) for acute treatment of migraine; results hav…

• CLINICAL_TRIALS trial_result · 2025-02-10
  Clinical Trial Update: Hydration in Children and Adolescents With Primary Headaches [NA]

  This clinical trial update reports the completion of a study evaluating whether hydration benefits children and adolescents with primary hea…

• CLINICAL_TRIALS trial_result · 2025-02-06
  Clinical Trial Update: Work-related Burden Changes, Quantified with HEADWORK, Among Individuals Treated with Migraine Preventive Therapies.

  This trial update reports changes in work-related burden among people treated with migraine preventive therapies, as measured by the HEADWOR…

• CLINICAL_TRIALS trial_result · 2025-01-31
  Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine [Phase 3]

  A Phase 3 randomized, double-blind, placebo-controlled study of fremanezumab in Chinese adults with migraine has completed, including an ope…

• CLINICAL_TRIALS trial_result · 2025-01-29
  Clinical Trial Update: Examination of Muscle Stiffness, Tenderness and Pressure Pain Thresholds During a Cycle of Botulinum Toxin A Treatment in Chronic Migraine Patients

  A completed study examining muscle stiffness, tenderness, and pressure pain thresholds during Botulinum toxin A treatment in chronic migrain…

• CLINICAL_TRIALS trial_result · 2025-01-29
  Clinical Trial Update: Evaluation of a Mind-body Based Application for the Treatment of Chronic/Persistent Pain. [NA]

  This update reports the completed clinical trial results for a mind-body based digital application intended to treat chronic pain and migrai…